Main article II: Global Fund Technical Review Panel Recruitment
The Global Fund to Fight AIDS, Tuberculosis and Malaria is recruiting experts to serve on the Technical Review Panel (TRP).
The Global Fund was created to finance, attract, manage and disburse additional resources to make a sustainable and significant contribution to mitigate the impact caused by HIV/AIDS, tuberculosis and malaria in countries in need, and contributing to poverty reduction. The Technical Review Panel (TRP), which has 26 members, plays a crucial role in reviewing proposals submitted to the Global Fund and ensuring that those funded are of high quality. The TRP consists of 11 cross-cutters, 7 HIV-AIDS experts, 4 Malaria experts and 4 Tuberculosis experts.
Individuals with expert technical knowledge and extensive experience in one of the following are sought:
- HIV/AIDS
- Tuberculosis
- Malaria
- Cross cutting issues (such as institutional and governance issues, macro-economics in a health sector context)
The current term of appointment is three rounds of proposals; however the Board is considering its extension to four rounds. Members will be paid an honorarium and their expenses. They must be available for the two week TRP meetings in Geneva every 8 to 12 months. The next meeting is in early May 2004. Fluency in English is required as this is the working language of the TRP.
A transparent criteria-based selection process will be followed which seeks to achieve a significant proportion of members from each of the WHO regions, representation from public and private sectors and civil society, including a qualified member from the Persons Living with AIDS community. A balanced gender representation is sought.
An Application Form can be downloaded from the website of the Global Fund: http://www.globalfundatm.org
or the Health Systems Resource Centre's website: http://www.healthsystemsrc.org.
Completed application forms in English (no CVs) should be sent to: globalfund.trp@ihsd.org to arrive no later than 9.00 am European time (8am UK time) on Monday 17th November, 2003.
Applicants without access to email should contact the local WHO or UNAIDS office for assistance.
About HATIP
A regular electronic newsletter for health care workers and community-based organisations on HIV treatment in resource-limited settings.
Its publication is supported by the UK government's Department for International Development (DfID), the Diana, Princess of Wales Memorial Fund and the Stop TB Department of the World Health Organization.
Other supporters include Positive Action GlaxoSmithKline (founding sponsor); Abbott Fund; Abbott Molecular; Cavidi; Elton John AIDS Foundation; Merck & Co., Inc.; Pfizer Ltd; F Hoffmann La Roche; Schering Plough; and Tibotec, a division of Janssen Cilag.
latest aidsmap news
- Large HIV vaccine study will not go ahead
- Swiss court rules all people with HIV can be criminally liable for transmission, even if untested
- Genital shedding of HIV in women with undetectable viral load: less of it, but still happening
- Microbicides could prevent more infections in men than in women
- Knowledge of STIs poor in rural Tanzania - associated with risky sex and infection with HIV
- HIV treatment effective for infants in resource-limited settings
- Need for vigilance: two cases of abacavir allergy despite pre-treatment screening all-clear
- One third of people with HIV have experienced sexual difficulties in the past month
- Differing causes of lung infections in HIV-positive patients: implications for diagnosis and treatment
- Roche to halt HIV drug research
